356 related articles for article (PubMed ID: 32547555)
1. Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis.
Kang M; Choi JK; Jittayasothorn Y; Egwuagu CE
Front Immunol; 2020; 11():1051. PubMed ID: 32547555
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Regulatory B Cells in Experimental Autoimmune Uveitis.
Choi JK; Egwuagu CE
Methods Mol Biol; 2021; 2270():437-450. PubMed ID: 33479912
[TBL] [Abstract][Full Text] [Related]
3. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases.
Choi JK; Yu CR; Bing SJ; Jittayasothorn Y; Mattapallil MJ; Kang M; Park SB; Lee HS; Dong L; Shi G; Caspi RR; Egwuagu CE
Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34782464
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 35-Producing B Cells (i35-Breg): A New Mediator of Regulatory B-Cell Functions in CNS Autoimmune Diseases.
Egwuagu CE; Yu CR
Crit Rev Immunol; 2015; 35(1):49-57. PubMed ID: 25746047
[TBL] [Abstract][Full Text] [Related]
5. Production of IL-35 by Bregs is mediated through binding of BATF-IRF-4-IRF-8 complex to il12a and ebi3 promoter elements.
Yu CR; Choi JK; Uche AN; Egwuagu CE
J Leukoc Biol; 2018 Dec; 104(6):1147-1157. PubMed ID: 30117603
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 35 Regulatory B Cells.
Choi JK; Egwuagu CE
J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
[TBL] [Abstract][Full Text] [Related]
7. IL-27-containing exosomes secreted by innate B-1a cells suppress and ameliorate uveitis.
Kang M; Yadav MK; Mbanefo EC; Yu CR; Egwuagu CE
Front Immunol; 2023; 14():1071162. PubMed ID: 37334383
[TBL] [Abstract][Full Text] [Related]
8. Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.
Wang RX; Yu CR; Mahdi RM; Egwuagu CE
J Biol Chem; 2012 Oct; 287(43):36012-21. PubMed ID: 22936807
[TBL] [Abstract][Full Text] [Related]
9. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
10. STAT3 deficiency in B cells exacerbates uveitis by promoting expansion of pathogenic lymphocytes and suppressing regulatory B cells (Bregs) and Tregs.
Oladipupo FO; Yu CR; Olumuyide E; Jittaysothorn Y; Choi JK; Egwuagu CE
Sci Rep; 2020 Oct; 10(1):16188. PubMed ID: 33004854
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-35 induces regulatory B cells that suppress autoimmune disease.
Wang RX; Yu CR; Dambuza IM; Mahdi RM; Dolinska MB; Sergeev YV; Wingfield PT; Kim SH; Egwuagu CE
Nat Med; 2014 Jun; 20(6):633-41. PubMed ID: 24743305
[TBL] [Abstract][Full Text] [Related]
12. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
Front Immunol; 2021; 12():724609. PubMed ID: 34603297
[TBL] [Abstract][Full Text] [Related]
13. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
Front Immunol; 2020; 11():2071. PubMed ID: 33013877
[TBL] [Abstract][Full Text] [Related]
14. IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease.
Dambuza IM; He C; Choi JK; Yu CR; Wang R; Mattapallil MJ; Wingfield PT; Caspi RR; Egwuagu CE
Nat Commun; 2017 Sep; 8(1):719. PubMed ID: 28959012
[TBL] [Abstract][Full Text] [Related]
15. SOCS3 deletion in T lymphocytes suppresses development of chronic ocular inflammation via upregulation of CTLA-4 and expansion of regulatory T cells.
Yu CR; Kim SH; Mahdi RM; Egwuagu CE
J Immunol; 2013 Nov; 191(10):5036-43. PubMed ID: 24101549
[TBL] [Abstract][Full Text] [Related]
16. Key role for IL-21 in experimental autoimmune uveitis.
Wang L; Yu CR; Kim HP; Liao W; Telford WG; Egwuagu CE; Leonard WJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9542-7. PubMed ID: 21593413
[TBL] [Abstract][Full Text] [Related]
17. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
18. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of the Interphotoreceptor Retinoid Binding ProteinInduced Models of Experimental Autoimmune Uveitis in B10.RIII versus C57BL/6 Mice.
Chen Y; Chen Z; Chong WP; Wu S; Wang W; Zhou H; Chen J
Curr Mol Med; 2018; 18(9):602-611. PubMed ID: 30636608
[TBL] [Abstract][Full Text] [Related]
20. Retinal cells suppress intraocular inflammation (uveitis) through production of interleukin-27 and interleukin-10.
Lee YS; Amadi-Obi A; Yu CR; Egwuagu CE
Immunology; 2011 Apr; 132(4):492-502. PubMed ID: 21294722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
